Jin-hyeob Ryu
Yuseong, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis.
Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis.
Journal: International journal of molecular sciences
Published: December 05, 2025
Investigating Neuroprotective Effects of Berberine on Mitochondrial Dysfunction and Autophagy Impairment in Parkinson's Disease.
Journal: International journal of molecular sciences
Published: June 24, 2025
l-Type amino acid transporter 1-targeting nanoparticles for antisense oligonucleotide delivery to the CNS.
Journal: Molecular therapy. Nucleic acids
Published: April 04, 2024
ASOptimizer: Optimizing antisense oligonucleotides through deep learning for IDO1 gene regulation.
Journal: Molecular therapy. Nucleic acids
Published: October 17, 2023
The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer's disease.
Journal: Clinical biochemistry
Published: November 15, 2022
The role of microRNA-485 in neurodegenerative diseases.
Journal: Reviews in the neurosciences
Published: April 08, 2022
Correction: Koh et al. Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression. Int. J. Mol. Sci. 2021, 22, 13136.
Journal: International journal of molecular sciences
Published: January 19, 2022
miRNAs as Therapeutic Tools in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: November 05, 2021
Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression.
Journal: International journal of molecular sciences
Published: October 04, 2021
Influenza Viruses: Innate Immunity and mRNA Vaccines.
Journal: Frontiers in immunology
Published: May 17, 2021
Last Updated: 09/26/2026